PGR and meningioma: The antiproliferative effect of RU486 in normal or neoplastic cells appears to be complex; its action was found to be dependent on the interaction with progesterone receptor in cultured human meningioma cells (35) or with glucocorticoid receptor, in prostate cancer cells (13).